Clinical Trial Update: Exhaled Levels of Nitric Oxide [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated exhaled nitric oxide levels in participants with tetraplegia and asthma; results have been posted following completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Tetraplegia

Snippet

Sponsor: VA Office of Research and Development | Conditions: Tetraplegia, Asthma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-07-04